Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)
Hong Kong · Delayed Price · Currency is HKD 27.72
-1.32 (-4.55%)
Sep 23, 2026, 3:59 PM HKT
HKG:2651 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
| 1,669 | 453 | - | - | - | - | |
Market Cap Growth | 145.30% | - | - | - | - | - |
Enterprise Value | 1,530 | 530 | - | - | - | - |
Last Close Price | 27.50 | 8.06 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
PE Ratio | 55.15 | 14.45 | - | - | - | - |
PS Ratio | 3.95 | 1.10 | - | - | - | - |
PB Ratio | 4.14 | 1.09 | - | - | - | - |
P/TBV Ratio | 6.19 | 1.60 | - | - | - | - |
P/FCF Ratio | 20.25 | 5.04 | - | - | - | - |
P/OCF Ratio | 17.78 | 4.33 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
EV/Sales Ratio | 3.62 | 1.28 | - | - | - | - |
EV/EBITDA Ratio | 12.42 | 5.93 | - | - | - | - |
EV/EBIT Ratio | 22.09 | 8.01 | - | - | - | - |
EV/FCF Ratio | 18.56 | 5.89 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
Debt / Equity Ratio | 0.20 | 0.20 | 0.71 | 0.59 | 0.79 | - |
Debt / EBITDA Ratio | 0.64 | 0.67 | 0.89 | 0.70 | 0.87 | - |
Debt / FCF Ratio | 0.95 | 0.93 | 1.47 | 0.78 | 1.06 | - |
Net Debt / Equity Ratio | -0.49 | -0.56 | 0.11 | -0.73 | -0.47 | -0.09 |
Net Debt / EBITDA Ratio | -2.18 | -2.63 | 0.20 | -1.17 | -0.73 | -0.26 |
Net Debt / FCF Ratio | -2.39 | -2.61 | 0.23 | -0.96 | -0.62 | 0.71 |
Asset Turnover | 0.88 | 0.83 | 0.94 | 0.93 | - | 1.53 |
Inventory Turnover | 53.16 | 76.30 | 54.41 | 46.23 | - | 20.33 |
Quick Ratio | 2.84 | 3.26 | 0.77 | 0.96 | 1.49 | 1.11 |
Current Ratio | 3.24 | 3.35 | 0.90 | 1.00 | 1.58 | 1.71 |
Return on Equity (ROE) | 16.80% | 18.98% | 37.86% | 42.84% | - | 25.12% |
Return on Assets (ROA) | 9.02% | 8.32% | 10.12% | 11.07% | - | 16.44% |
Return on Invested Capital (ROIC) | 29.48% | 30.56% | 55.71% | 117.85% | 97.28% | 28.27% |
Return on Capital Employed (ROCE) | 15.20% | 14.00% | 29.00% | 34.70% | 19.90% | 27.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
Earnings Yield | 1.87% | 6.92% | - | - | - | - |
FCF Yield | 4.94% | 19.84% | - | - | - | - |
Dividend Yield | 2.35% | 7.69% | - | - | - | - |
Payout Ratio | 130.28% | 68.84% | 73.01% | 73.10% | 89.98% | 58.69% |
Buyback Yield / Dilution | -49.34% | -12.05% | 5.09% | - | -72.98% | -44.01% |
Total Shareholder Return | -46.99% | -4.36% | 5.09% | - | -72.98% | -44.01% |